0001209191-16-145584.txt : 20161011 0001209191-16-145584.hdr.sgml : 20161011 20161011163746 ACCESSION NUMBER: 0001209191-16-145584 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161007 FILED AS OF DATE: 20161011 DATE AS OF CHANGE: 20161011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huber Reid M CENTRAL INDEX KEY: 0001607052 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 161931467 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION, EXPERIMENTAL STN STREET 2: ROUTE 141 & HENRY CLAY ROAD, BLDG. E336 CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-10-07 0 0000879169 INCYTE CORP INCY 0001607052 Huber Reid M 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, Chief Scientific Officer Common Stock 2016-10-07 4 M 0 11709 18.32 A 78310 D Common Stock 2016-10-07 4 S 0 11709 96.40 D 66601 D Non-Qualified Stock Option (right to buy) 18.32 2016-10-07 4 M 0 11709 0.00 D 2020-02-08 Common Stock 11709 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. Represents weighted average sale price. Actual sale prices ranged from $95.24 - $97.00 Includes an aggregate of 27,496 shares of common stock issuable to previously reported restricted stock units that have not vested. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Eric H. Siegel, Attorney-In-Fact 2016-10-11